It was a pleasure to talk to Pat Penovich (Minnesota Epilepsy Group, St. Paul, MN, USA) about the exit survey, of a Phase 3 study, assessing patient experience of using the diazepam nasal spray for seizure clusters. The abstract ‘Examining the Patient Experience With Diazepam Nasal Spray for Seizure Clusters: Patient-reported Results From an Exit Survey of a Phase 3, Open-label, Repeat Dose Safety Study.’ was presented at the virtual AES 2020, 4-8 December 2020.
- What are the advantages of intranasal delivery of rescue medications compared with current options in patients with epilepsy clusters? (0:05)
- Could you tell us a little about the diazepam nasal spray and it’s indications? (1:36)
- Could you give us an overview of your recent study on patient experience with diazepam nasal spray? (2:44)
- What were the findings of the study and what are the implications for future clinical practice? (3:50)
- Which patients are most likely to benefit from the diazepam nasal spray? (5:12)
Disclosures: Consultant and on Speaker’s Bureau for Neurelis, SK and UCB; Speaker’s Bureau for Greenwich; and Consultant for Marinus and LVIS.
Support: Interview and filming supported by Touch Medical Media.
Filmed as a highlight of AES 2020, 4-8 December, 2020 (Virtual).
Share this Video
Related Videos In Epilepsy
Kimford Meador, AAN 2021: Fetal Antiseizure Medication in Pregnant Women with Epilepsy
It was a great pleasure to meet with Kimford Meador (Stanford University, Stanford, CA, USA) to discuss the effects and use of antiseizure medications during pregnancy, in women with epilepsy. The abstract entitled: ‘Fetal Antiseizure Medication Effects on Neuropsychological Outcomes at Age 3 Years in the MONEAD Study’ was presented at the American Academy of […]
Kimford Meador, AAN 2021: Preliminary findings of the MONEAD Study
It was a great pleasure to meet with Kimford Meador (Stanford University, Stanford, CA, USA) to discuss the aims, design and preliminary findings from the MONEAD study, and what these results mean for treatment of epilepsy in pregnant women. The abstract entitled: ‘Fetal Antiseizure Medication Effects on Neuropsychological Outcomes at Age 3 Years in the […]
Michael Sperling, AAN 2021: Post-hoc Analysis of Cenobamate for Uncontrolled Focal Seizures
We were delighted to speak with Michael Sperling (Thomas Jefferson University, Philadelphia, PA, USA) to discuss the recent post-hoc analysis of cenobamate for uncontrolled focal seizures, and its intended place in the treatment landscape for epilepsy. The abstract entitled: ‘Efficacy of Cenobamate for Uncontrolled Focal Seizures: Post-hoc Analysis of a Phase 3, Multicenter, Open-Label Study’ […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!